Suchergebnisse - "administration & dosage)"

Comparative assessment of oral medications for overactive bladder in older adults: a systematic review and network meta-analysis.

Autoren: He W Wang C Chen B et al.

Quelle: The aging male : the official journal of the International Society for the Study of the Aging Male [Aging Male] 2025 Dec 11; Vol. 28 (1), pp. 2568729. Date of Electronic Publication: 2025 Oct 29.

Publikationsart: Journal Article; Systematic Review; Meta-Analysis; Comparative Study; Review

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9808210 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-0790 (Electronic) Linking ISSN: 13685538 NLM ISO Abbreviation: Aging Male Subsets: MEDLINE

MeSH-Schlagworte: Urinary Bladder, Overactive*/drug therapy , Muscarinic Antagonists*/administration & dosage , Muscarinic Antagonists*/adverse effects , Muscarinic Antagonists*/therapeutic use , Urological Agents*/administration & dosage , Urological Agents*/adverse effects , Urological Agents*/therapeutic use, Humans ; Aged ; Network Meta-Analysis as Topic ; Administration, Oral ; Benzilates/administration & dosage ; Benzilates/adverse effects ; Benzilates/therapeutic use ; Nortropanes/administration & dosage ; Nortropanes/adverse effects ; Nortropanes/therapeutic use ; Benzhydryl Compounds/administration & dosage ; Benzhydryl Compounds/adverse effects ; Tolterodine Tartrate/administration & dosage ; Tolterodine Tartrate/adverse effects ; Tolterodine Tartrate/therapeutic use ; Acetanilides/administration & dosage ; Acetanilides/adverse effects ; Acetanilides/therapeutic use ; Thiazoles/administration & dosage ; Thiazoles/adverse effects ; Thiazoles/therapeutic use ; Randomized Controlled Trials as Topic ; Pyrrolidines/administration & dosage ; Pyrrolidines/adverse effects ; Pyrrolidines/therapeutic use ; Male ; Pyrimidinones

Innate immune mechanisms underlying the efficacy of a next-generation nanoparticle-based vaccine against opioid use disorders.

Autoren: Hamid FA Rostamizadeh K Skiados N et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 1), pp. 114294. Date of Electronic Publication: 2025 Oct 06.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Vaccines*/administration & dosage , Vaccines*/immunology , Nanoparticles*/administration & dosage , Nanoparticles*/chemistry , Opioid-Related Disorders*/immunology , Opioid-Related Disorders*/prevention & control , Oxycodone*/immunology , Oxycodone*/administration & dosage, Animals ; Immunity, Innate/drug effects ; Male ; Rats, Sprague-Dawley ; Fentanyl/immunology ; Fentanyl/administration & dosage ; Rats ; Female ; Analgesics, Opioid/administration & dosage ; Mice ; Lipids/chemistry ; Humans

A ratiometric theranostic nanoplatform with acid-triggered drug release and glutathione-activated fluorescence turn-on.

Autoren: Flores-Cruz RD Figueroa-DePaz Y Lobita MC et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 1), pp. 114309. Date of Electronic Publication: 2025 Oct 10.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Glutathione*/metabolism , Glutathione*/chemistry , Antineoplastic Agents*/administration & dosage , Antineoplastic Agents*/chemistry , Coordination Complexes*/administration & dosage , Coordination Complexes*/chemistry, Humans ; Animals ; Quantum Dots/chemistry ; Quantum Dots/administration & dosage ; Drug Liberation ; Theranostic Nanomedicine/methods ; Zebrafish ; Folic Acid/chemistry ; Female ; Zinc Oxide/chemistry ; Zinc Oxide/administration & dosage ; Cell Line, Tumor ; Fluorescence ; Copper/chemistry ; Copper/administration & dosage ; Fluorescent Dyes/administration & dosage ; Fluorescent Dyes/chemistry ; Drug Delivery Systems

Multi-interfacial microbubbles controlled sequential cavitation for synergistic vascular destruction/chemotherapeutic therapy.

Autoren: Chen T Zhang C Zhao Y et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 1), pp. 114287. Date of Electronic Publication: 2025 Oct 01.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/administration & dosage , Doxorubicin*/therapeutic use , Doxorubicin*/chemistry , Doxorubicin*/pharmacokinetics , Microbubbles* , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use , Neoplasms*/drug therapy, Animals ; Nanoparticles/chemistry ; Nanoparticles/administration & dosage ; Humans ; Silicon Dioxide/chemistry ; Silicon Dioxide/administration & dosage ; Drug Delivery Systems ; Cell Line, Tumor ; Mice ; Female

Highly adhesive asynchronous drug-releasing membrane for facial care: Combined anti-acne and anti-inflammatory properties.

Autoren: Kang D Xue C Cai B et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 1), pp. 114260. Date of Electronic Publication: 2025 Sep 27.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Anti-Inflammatory Agents*/administration & dosage , Anti-Inflammatory Agents*/chemistry , Anti-Inflammatory Agents*/pharmacology , Anti-Bacterial Agents*/administration & dosage , Anti-Bacterial Agents*/chemistry , Anti-Bacterial Agents*/pharmacology , Acne Vulgaris*/drug therapy , Dihydroxyphenylalanine*/chemistry , Dihydroxyphenylalanine*/administration & dosage, Animals ; Humans ; Propionibacterium acnes/drug effects ; Drug Liberation ; Polyvinyl Alcohol/chemistry ; Nanofibers/chemistry ; Nanofibers/administration & dosage ; Polylysine/chemistry ; Gelatin/chemistry ; Rats ; Membranes, Artificial ; Face ; Male ; Antioxidants/administration & dosage ; Delayed-Action Preparations

Hydrogel formulations for sustained-release of broadly neutralizing antibodies.

Autoren: Jons CK Kasse CM Mayer BT et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 2), pp. 114349. Date of Electronic Publication: 2025 Oct 31.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Hydrogels*/chemistry , Hydrogels*/administration & dosage , Antibodies, Neutralizing*/administration & dosage , Broadly Neutralizing Antibodies*/administration & dosage, Animals ; Delayed-Action Preparations/pharmacokinetics ; Delayed-Action Preparations/administration & dosage ; Delayed-Action Preparations/chemistry ; Mice ; Humans ; Female ; Rats ; Nanoparticles/chemistry ; Nanoparticles/administration & dosage ; Male ; Drug Liberation ; Rats, Sprague-Dawley

Hydroxyapatite and doxorubicin-laden nanotherapeutics for effective multimodality cancer treatment boosted via mitochondrial calcium overload.

Autoren: Chang YS Sabu A Kandel M et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 2), pp. 114368. Date of Electronic Publication: 2025 Nov 02.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Doxorubicin*/administration & dosage , Doxorubicin*/therapeutic use , Doxorubicin*/chemistry , Calcium*/metabolism , Durapatite*/chemistry , Durapatite*/administration & dosage , Nanoparticles*/chemistry , Nanoparticles*/administration & dosage , Antibiotics, Antineoplastic*/administration & dosage , Antibiotics, Antineoplastic*/therapeutic use , Triple Negative Breast Neoplasms*/therapy , Triple Negative Breast Neoplasms*/pathology , Triple Negative Breast Neoplasms*/drug therapy, Animals ; Humans ; Female ; Cell Line, Tumor ; Mitochondria/metabolism ; Mitochondria/drug effects ; Bismuth/chemistry ; Bismuth/administration & dosage ; Cell Survival/drug effects ; Mice, Nude ; Combined Modality Therapy ; Mice ; Mice, Inbred BALB C ; Silicon Dioxide/chemistry ; Sulfides/chemistry ; Sulfides/administration & dosage ; Photothermal Therapy ; Polyethylene Glycols/chemistry

Control of pharmacokinetics of radioimmunoconjugates using chelating agents containing poly(ethylene glycol).

Autoren: Nakashima K Jinda H Shimohara H et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 1), pp. 114293. Date of Electronic Publication: 2025 Oct 05.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Polyethylene Glycols*/chemistry , Polyethylene Glycols*/pharmacokinetics , Chelating Agents*/chemistry , Chelating Agents*/pharmacokinetics , Chelating Agents*/administration & dosage , Immunoconjugates*/pharmacokinetics , Immunoconjugates*/administration & dosage , Immunoconjugates*/chemistry, Animals ; Humans ; Cell Line, Tumor ; Female ; Tissue Distribution ; Trastuzumab/pharmacokinetics ; Trastuzumab/administration & dosage ; Heterocyclic Compounds, 1-Ring/chemistry ; Heterocyclic Compounds, 1-Ring/pharmacokinetics ; Mice, Nude ; Mice ; Mice, Inbred BALB C ; Receptor, ErbB-2/metabolism ; Radioisotopes/pharmacokinetics ; Radioisotopes/administration & dosage ; Maleimides/chemistry

Squalene-adenosine nanoparticles enhance cardioprotection in myocardial infarction: Efficacy and mechanistic insights.

Autoren: Saludas L Garbayo E Abizanda G et al.

Quelle: Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2025 Dec 10; Vol. 388 (Pt 2), pp. 114369. Date of Electronic Publication: 2025 Oct 30.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE

MeSH-Schlagworte: Myocardial Infarction*/drug therapy , Myocardial Infarction*/pathology , Myocardial Infarction*/metabolism , Cardiotonic Agents*/administration & dosage , Cardiotonic Agents*/therapeutic use , Nanoparticles*/administration & dosage , Nanoparticles*/chemistry , Adenosine*/administration & dosage , Adenosine*/therapeutic use , Adenosine*/chemistry , Squalene*/administration & dosage , Squalene*/chemistry , Squalene*/therapeutic use, Animals ; Male ; Rats, Sprague-Dawley ; Myocardial Reperfusion Injury/drug therapy ; Rats ; Antioxidants/administration & dosage ; Antioxidants/therapeutic use ; Vitamin E/administration & dosage ; Vitamin E/therapeutic use ; Myocytes, Cardiac/drug effects

Co-administration of a synthetic saccharide conjugate vaccine with BCG provides synergistic protection against murine tuberculosis.

Autoren: Miranda-Hernandez S Sathkumara HD Zhao G et al.

Quelle: Vaccine [Vaccine] 2025 Dec 05; Vol. 68, pp. 127912. Date of Electronic Publication: 2025 Oct 29.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2518 (Electronic) Linking ISSN: 0264410X NLM ISO Abbreviation: Vaccine Subsets: MEDLINE

MeSH-Schlagworte: BCG Vaccine*/immunology , BCG Vaccine*/administration & dosage , Tuberculosis*/prevention & control , Tuberculosis*/immunology , Tuberculosis Vaccines*/immunology , Tuberculosis Vaccines*/administration & dosage, Animals ; Vaccines, Conjugate/immunology ; Vaccines, Conjugate/administration & dosage ; Mice ; Female ; Mycobacterium tuberculosis/immunology ; Vaccines, Synthetic/immunology ; Vaccines, Synthetic/administration & dosage ; Disease Models, Animal ; Mice, Inbred C57BL ; Phosphatidylinositols/immunology

Co-delivery of spiramycin and curcumin nanoemulsions for treating acute (RH strain) and chronic (Tehran strain) toxoplasmosis in BALB/c mice.

Autoren: Hashemi-Hafshejani S Amani A Azami SJ et al.

Quelle: Parasitology research [Parasitol Res] 2025 Dec 02; Vol. 124 (12), pp. 148. Date of Electronic Publication: 2025 Dec 02.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Springer International Country of Publication: Germany NLM ID: 8703571 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-1955 (Electronic) Linking ISSN: 09320113 NLM ISO Abbreviation: Parasitol Res Subsets: MEDLINE

MeSH-Schlagworte: Spiramycin*/administration & dosage , Spiramycin*/pharmacokinetics , Spiramycin*/pharmacology , Curcumin*/administration & dosage , Curcumin*/pharmacokinetics , Curcumin*/pharmacology , Toxoplasma*/drug effects , Toxoplasmosis, Animal*/drug therapy , Toxoplasmosis, Animal*/parasitology , Antiprotozoal Agents*/administration & dosage , Antiprotozoal Agents*/pharmacokinetics, Animals ; Mice, Inbred BALB C ; Emulsions/administration & dosage ; Mice ; Disease Models, Animal ; Female ; Survival Analysis ; Treatment Outcome ; Nanoparticles/administration & dosage ; Parasite Load ; Particle Size

Antifungal prophylaxis in patients with FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD)-positive acute myeloid leukaemia receiving sorafenib during initial induction and consolidation treatment in ALLG AMLM16 trial.

Autoren: Neoh CF Yong MK Rowley L et al.

Quelle: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Dec 02; Vol. 80 (12), pp. 3401-3406.

Publikationsart: Journal Article; Randomized Controlled Trial

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

MeSH-Schlagworte: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/complications , Leukemia, Myeloid, Acute*/genetics , fms-Like Tyrosine Kinase 3*/genetics , Antifungal Agents*/therapeutic use , Antifungal Agents*/administration & dosage , Antifungal Agents*/adverse effects , Phenylurea Compounds*/therapeutic use , Phenylurea Compounds*/adverse effects , Antineoplastic Agents*/therapeutic use , Antineoplastic Agents*/adverse effects , Niacinamide*/analogs & derivatives , Niacinamide*/therapeutic use , Niacinamide*/adverse effects , Niacinamide*/administration & dosage , Invasive Fungal Infections*/prevention & control , Chemoprevention*/methods, Humans ; Sorafenib ; Middle Aged ; Male ; Female ; Adult ; Double-Blind Method ; Aged ; Amphotericin B/administration & dosage ; Amphotericin B/therapeutic use ; Amphotericin B/adverse effects ; Placebos/administration & dosage ; Young Adult ; Induction Chemotherapy ; Consolidation Chemotherapy

Efficacy of topical hydrophilic gel of paromomycin combined with systemic or locally administered leishmanicidal drugs for treatment of experimental leishmaniasis caused by Leishmania (Viannia) braziliensis.

Autoren: Alves LL Pinheiro Rosa DC Freire ML et al.

Quelle: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2025 Dec 02; Vol. 80 (12), pp. 3278-3287.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE

MeSH-Schlagworte: Paromomycin*/administration & dosage , Antiprotozoal Agents*/administration & dosage , Leishmaniasis, Cutaneous*/drug therapy , Leishmaniasis, Cutaneous*/parasitology , Leishmania braziliensis*/drug effects , Leishmania braziliensis*/isolation & purification, Animals ; Amphotericin B/administration & dosage ; Meglumine Antimoniate ; Drug Therapy, Combination/methods ; Treatment Outcome ; Organometallic Compounds/administration & dosage ; Parasite Load ; Administration, Topical ; Female ; Disease Models, Animal ; Gels/administration & dosage ; Mice ; Meglumine/administration & dosage ; Spleen/parasitology

The Therapeutic Effects of a Bentonite-Based Facial Mask With Alcea sulphurea Extract on Acne Severity and Patient Experience: Add-On Randomized Controlled Clinical Trial.

Autoren: Salimi S Fakhri M Saeedi M et al.

Quelle: Journal of cosmetic dermatology [J Cosmet Dermatol] 2025 Dec; Vol. 24 (12), pp. e70586.

Publikationsart: Journal Article; Randomized Controlled Trial

Info zur Zeitschrift: Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print Cited Medium: Internet ISSN: 1473-2165 (Electronic) Linking ISSN: 14732130 NLM ISO Abbreviation: J Cosmet Dermatol Subsets: MEDLINE

MeSH-Schlagworte: Acne Vulgaris*/drug therapy , Acne Vulgaris*/therapy , Acne Vulgaris*/diagnosis , Bentonite*/administration & dosage , Plant Extracts*/administration & dosage , Masks*, Humans ; Female ; Male ; Adult ; Severity of Illness Index ; Young Adult ; Patient Satisfaction ; Treatment Outcome ; Azithromycin/administration & dosage ; Adolescent ; Double-Blind Method ; Anti-Bacterial Agents/administration & dosage ; Quality of Life

Albumin-bound paclitaxel and cisplatin with radiotherapy in locally advanced oesophageal squamous cell carcinoma: a single-arm, phase II trial.

Autoren: Yang S Jiang H Zhong L et al.

Quelle: BMC cancer [BMC Cancer] 2025 Dec 01; Vol. 25 (1), pp. 1840. Date of Electronic Publication: 2025 Dec 01.

Publikationsart: Journal Article; Clinical Trial, Phase II

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

MeSH-Schlagworte: Cisplatin*/administration & dosage , Cisplatin*/adverse effects , Esophageal Squamous Cell Carcinoma*/therapy , Esophageal Squamous Cell Carcinoma*/pathology , Esophageal Squamous Cell Carcinoma*/mortality , Esophageal Neoplasms*/therapy , Esophageal Neoplasms*/pathology , Esophageal Neoplasms*/mortality , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Chemoradiotherapy*/methods , Chemoradiotherapy*/adverse effects , Albumin-Bound Paclitaxel*/administration & dosage , Albumin-Bound Paclitaxel*/adverse effects, Humans ; Male ; Female ; Middle Aged ; Aged ; Albumins/administration & dosage ; Paclitaxel/administration & dosage

Efficacy and Safety of Oral 5-FU Derivatives After Progression of HR ⁺ /HER2 ^- Metastatic Breast Cancer on CDK4/6 Inhibitor.

Autoren: Koi Y Tajiri W Kawasaki J et al.

Quelle: Anticancer research [Anticancer Res] 2025 Dec; Vol. 45 (12), pp. 5609-5618.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 8102988 Publication Model: Print Cited Medium: Internet ISSN: 1791-7530 (Electronic) Linking ISSN: 02507005 NLM ISO Abbreviation: Anticancer Res Subsets: MEDLINE

MeSH-Schlagworte: Breast Neoplasms*/drug therapy , Breast Neoplasms*/pathology , Breast Neoplasms*/metabolism , Cyclin-Dependent Kinase 4*/antagonists & inhibitors , Cyclin-Dependent Kinase 6*/antagonists & inhibitors , Fluorouracil*/administration & dosage , Fluorouracil*/adverse effects , Fluorouracil*/therapeutic use , Fluorouracil*/analogs & derivatives , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/administration & dosage, Humans ; Female ; Middle Aged ; Aged ; Receptor, ErbB-2/metabolism ; Retrospective Studies ; Adult ; Aminopyridines/administration & dosage ; Administration, Oral ; Disease Progression ; Receptors, Progesterone/metabolism ; Receptors, Estrogen/metabolism ; Benzimidazoles/administration & dosage ; Treatment Outcome ; Neoplasm Metastasis ; Tegafur/administration & dosage ; Drug Combinations

Enhancing Facial Rejuvenation Outcomes With a Novel Retinaldehyde-Based Cream: A Comparative Randomized Intra-Individual Study.

Autoren: Monteil C Barreto-Campos V Lain E et al.

Quelle: Journal of cosmetic dermatology [J Cosmet Dermatol] 2025 Dec; Vol. 24 (12), pp. e70555.

Publikationsart: Journal Article; Randomized Controlled Trial; Comparative Study

Info zur Zeitschrift: Publisher: Blackwell Science Country of Publication: England NLM ID: 101130964 Publication Model: Print Cited Medium: Internet ISSN: 1473-2165 (Electronic) Linking ISSN: 14732130 NLM ISO Abbreviation: J Cosmet Dermatol Subsets: MEDLINE

MeSH-Schlagworte: Skin Aging*/drug effects , Rejuvenation* , Skin Cream*/administration & dosage , Skin Cream*/adverse effects , Retinaldehyde*/administration & dosage , Retinaldehyde*/adverse effects, Humans ; Female ; Middle Aged ; Niacinamide/administration & dosage ; Niacinamide/adverse effects ; Male ; Adult ; Treatment Outcome ; Face ; Hyaluronic Acid/administration & dosage ; Aged ; Plant Extracts/administration & dosage ; Plant Extracts/adverse effects ; Chemexfoliation

Transitioning barium enema preparation protocols to CT colonography in the modern imaging era.

Autoren: Tsurumaru D Nishimuta Y Nanjo K et al.

Quelle: Japanese journal of radiology [Jpn J Radiol] 2025 Dec; Vol. 43 (12), pp. 2063-2067. Date of Electronic Publication: 2025 Aug 09.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Springer Country of Publication: Japan NLM ID: 101490689 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1867-108X (Electronic) Linking ISSN: 18671071 NLM ISO Abbreviation: Jpn J Radiol Subsets: MEDLINE

MeSH-Schlagworte: Colonography, Computed Tomographic*/methods , Contrast Media*/administration & dosage , Barium Enema*/methods , Barium Sulfate* , Cathartics*/administration & dosage, Humans ; Male ; Female ; Aged ; Middle Aged ; Feasibility Studies ; Citric Acid/administration & dosage ; Aged, 80 and over ; Organometallic Compounds/administration & dosage ; Adult ; Colon/diagnostic imaging ; Enema/methods

Dual-Targeted Therapy in Cardiometabolic Risk: A Meta-Analysis of Telmisartan-Based Combinations for Hypertension and Dyslipidemia.

Autoren: Asim R Muhammad TS Ahmed S et al.

Quelle: Clinical cardiology [Clin Cardiol] 2025 Dec; Vol. 48 (12), pp. e70211.

Publikationsart: Journal Article; Meta-Analysis; Systematic Review

Info zur Zeitschrift: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 7903272 Publication Model: Print Cited Medium: Internet ISSN: 1932-8737 (Electronic) Linking ISSN: 01609289 NLM ISO Abbreviation: Clin Cardiol Subsets: MEDLINE

MeSH-Schlagworte: Telmisartan*/therapeutic use , Telmisartan*/administration & dosage , Dyslipidemias*/drug therapy , Dyslipidemias*/complications , Hypertension*/drug therapy , Hypertension*/physiopathology , Hypertension*/complications , Antihypertensive Agents*/therapeutic use , Antihypertensive Agents*/administration & dosage , Blood Pressure*/drug effects, Humans ; Drug Therapy, Combination ; Amlodipine/therapeutic use ; Amlodipine/administration & dosage ; Rosuvastatin Calcium/administration & dosage ; Rosuvastatin Calcium/therapeutic use ; Randomized Controlled Trials as Topic ; Treatment Outcome

Optimized dose schedule of rucaparib and liposomal irinotecan/5-fluorouracil in metastatic gastrointestinal cancers: A phase 1 study.

Autoren: Eslinger C Walden D Krivonos A et al.

Quelle: Cancer [Cancer] 2025 Dec 01; Vol. 131 (23), pp. e70184.

Publikationsart: Journal Article; Clinical Trial, Phase I

Info zur Zeitschrift: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

MeSH-Schlagworte: Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Antineoplastic Combined Chemotherapy Protocols*/administration & dosage , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/pharmacokinetics , Gastrointestinal Neoplasms*/drug therapy , Gastrointestinal Neoplasms*/pathology , Gastrointestinal Neoplasms*/genetics , Indoles*/administration & dosage , Indoles*/adverse effects , Indoles*/pharmacokinetics, Humans ; Female ; Middle Aged ; Male ; Aged ; Irinotecan/administration & dosage ; Irinotecan/adverse effects ; Fluorouracil/administration & dosage ; Fluorouracil/adverse effects ; Maximum Tolerated Dose ; Liposomes ; Adult ; Drug Administration Schedule ; Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage ; Neoplasm Metastasis ; Treatment Outcome